Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1748-717X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer ; volume:15 ; number:1 ; day:9 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
Radiation oncology ; 15, Heft 1 (9.6.2020), 1-9, 12.2020

Creator: Taugner, Julian
Eze, Chukwuka
Käsmann, Lukas
Roengvoraphoj, Olarn
Gennen, Kathrin
Karin, Monika
Petrukhnov, Oleg
Tufman, Amanda
Belka, Claus
Manapov, Farkhad

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13014-020-01590-8

URN: urn:nbn:de:101:1-2020080822312352174437

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Taugner, Julian
Eze, Chukwuka
Käsmann, Lukas
Roengvoraphoj, Olarn
Gennen, Kathrin
Karin, Monika
Petrukhnov, Oleg
Tufman, Amanda
Belka, Claus
Manapov, Farkhad
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons

Hochschulschrift

Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Magnetic resonance-guided radiation therapy: the beginning of a new era

$Prostate intra-fraction motion recorded by transperineal ultrasound$

Prostate intra-fraction motion recorded by transperineal ultrasound

The role of PDGF in radiation oncology

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

$Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy$

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Hochschulschrift

Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons

Hochschulschrift

Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Magnetic resonance-guided radiation therapy: the beginning of a new era

$Prostate intra-fraction motion recorded by transperineal ultrasound$

Prostate intra-fraction motion recorded by transperineal ultrasound

The role of PDGF in radiation oncology

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Hochschulschrift

Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons

Hochschulschrift

Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Magnetic resonance-guided radiation therapy: the beginning of a new era

$Prostate intra-fraction motion recorded by transperineal ultrasound$

Prostate intra-fraction motion recorded by transperineal ultrasound

The role of PDGF in radiation oncology

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons

Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Magnetic resonance-guided radiation therapy: the beginning of a new era

Prostate intra-fraction motion recorded by transperineal ultrasound

The role of PDGF in radiation oncology

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons

Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Magnetic resonance-guided radiation therapy: the beginning of a new era

Prostate intra-fraction motion recorded by transperineal ultrasound

The role of PDGF in radiation oncology

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons

Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

Magnetic resonance-guided radiation therapy: the beginning of a new era

Prostate intra-fraction motion recorded by transperineal ultrasound

The role of PDGF in radiation oncology

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Related objects

Reset password